Clinical and Post-Market
Demonstrate complete regulatory compliance by ensuring your in vitro diagnostic (IVD) device conforms to all applicable global requirements.
Delivering compliant IVD products to global markets
Choose Apotech for clinical compliance you can trust
Before placing an IVD device on the market, manufacturers must demonstrate compliance with all applicable global regulatory requirements including In Vitro Diagnostic Regulation (IVDR), 21 CFR and the UK MDR 2002.
At Apotech, our experienced team can make sure that you are conforming with the appropriate conformity assessment procedures. Working on your behalf, we can help you demonstrate that your IVD device achieves its intended purpose and corresponds to its claimed performance throughout its lifetime.
Trusted by top-tier teams worldwide
Why choose Apotech for IVD clinical and post-market services?
Article 56 (1) of the IVDR states that IVD manufacturers must specify and justify the level of clinical evidence given a device’s characteristics and its intended purpose. Therefore, defining this intended purpose must be considered a key driver behind its overall assessment.
Manufacturers must also ensure that they meet the essential requirements of the Medical Devices Regulations 2002 using data gathered through a performance evaluation.
At Apotech, we can support you during the clinical stages of your IVD development in the following areas:
FAQs on IVD clinical and post-market services
At Apotech, we provide a tailored approach to our IVD clinical and post-market services. We aim to make the process as simple to understand as possible and are always on hand to answer any questions you might have.
Here are some of the questions we get asked most often.
Featured case studies
Global in-country regulatory support
510(k) Submission Introduction Top 3 Global CRO Our client is one of the largest CROs globally, with operations present in every economy. Their services range from Clinical Development, Medical Affairs, and Commercial Delivery. Apotech continues to partner with them on a 3-year FSP contract. Apotech’s Consultants Our 18 strong Consulting team includes a mixture of…
Borderline device classification
Borderline device Classification Introduction Classification of borderline product (cosmetics VS medical device) Our client, a multinational cosmetics and wellness product manufacturer identified revenue opportunities marketing their cosmetics devices with increase claims. Apotech was engaged to perform a blanket regulatory assessment of cosmetic devices and provide judgement and pathways for market authorisation as a medical device…
GCP Mock inspections – Europe
GCP Mock inspections Europe Introduction Danish R&D Pharmaceutical Company Our client is a pharmaceutical company committed to ensuring compliance with global regulatory standards, particularly FDA requirements for clinical trials Apotech auditors Our Auditors have 20+ years’ experience, all based locally with extensive experience in FDA inspections and GCP compliance. Collectively conducted over 50 regulatory inspections…
- « Previous
- 1
- …
- 6
- 7
- 8